Ranbaxy: Biggest Drop Since Sept 2013
  • Prabha Hedge
  • Jan 24 2014

January 24: U.S. FDA has dealt yet another blow to India's largest drug maker as it prohibits Ranbaxy from making or selling drug ingredients from its Toansa plant for the U.S. market. Agam Vakil tells you what is the likely impact of this ban on the Ranbaxy stock.